FDA approves Novo Nordisk’s Victoza for cardiovascular disease treatment in type 2 diabetes patients

Novo Nordisk’s diabetes medication, Victoza (liraglutide), has gained U.S. Food and Drug Administration (FDA) approval for an expanded use, marking a significant step forward in ... Read More